Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Nucleic Acids|March 4, 2025
Enhanced hammerhead ribozyme turnover rates: Reevaluating therapeutic space for small catalytic RNAsJason M Myers, Jack M Sullivan
Journal of Cellular Biochemistry|March 21, 2003
Nuclear trafficking of FGFR1: a role for the transmembrane domainJason M Myers, Gabriel G Martins, Jacek Ostrowski, et al.
Molecular Pharmacology|September 1, 2012
Ifenprodil effects on GluN2B-containing glutamate receptorsStacy A Amico-Ruvio, Meaghan A Paganelli, Jason M Myers, et al.
Advances in Experimental Medicine and Biology|December 30, 2019
A Discovery with Potential to Revitalize Hammerhead Ribozyme Therapeutics for Treatment of Inherited Retinal DegenerationsAlexandria J Trujillo, Jason M Myers, Zahra S Fayazi, et al.
Molecular Biology of the Cell|February 17, 2006
Factors controlling fibroblast growth factor receptor-1's cytoplasmic trafficking and its regulation as revealed by FRAP analysisStar M Dunham-Ems, Haridas E Pudavar, Jason M Myers, et al.
Journal of Cellular Biochemistry|October 31, 2003
Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiationMichal K Stachowiak, Xiaohong Fang, Jason M Myers, et al.
Journal of Neurophysiology|September 21, 2012
Gating reaction mechanism of neuronal NMDA receptorsWilliam F Borschel, Jason M Myers, Eileen M Kasperek, et al.
Pageof 1